As Parkinson’s progresses, more invasive therapies are used, for example, those that require brain surgery. When these therapies no longer deliver the desired results, physicians often conclude that treatment options are exhausted. A study led by researchers at the Technical University of Munich (TUM) now shows that such patients can still benefit from a change in treatment. So far, however, this option has only been used very rarely.
Management of recurrent gastrointestinal cancer with ripretinib and surgery
Ripretinib is a tyrosine kinase inhibitor that was approved by the United States FDA in 2020 for treatment of advanced gastrointestinal stromal tumor (GIST) in patients who received prior treatment with three or more tyrosine kinase inhibitors.
Matthew Perry’s public struggle with addiction helped alleviate stigma, experts say
A year before his sudden death, “Friends” co-star Matthew Perry appeared on a podcast where he shared that he didn’t want to be remembered for his time on the sitcom, but for his work helping others with addiction.
Q&A: Researcher discusses genetics and biomarkers of frailty thesis
Frailty is an age-related state of physiological decline and is a strong predictor of disability and mortality. Researchers are trying to improve our understanding of the biology of frailty and to find ways of identifying frail older adults with the aim to improve individualized management of frailty.
Pancreas ‘crosstalk’ may influence course of type 1 and type 2 diabetes
In the largest study of its kind, researchers at Vanderbilt University Medical Center have identified unexpected alterations in the exocrine tissues of the pancreas that occur in the two major forms of diabetes, and with aging and obesity.
AAV-based gene therapies in non-human primates suggest integration into human DNA is unlikely to drive cancer mutations
Gene therapy adeno-associated viruses (AAVs)—viruses that can be engineered to deliver DNA to target cells—are unlikely to cause cancer-triggering insertions in humans or monkeys and may contribute to long-term efficacy, according to new research from the University of Pennsylvania’s Gene Therapy Program (GTP).
Boosting immune system in chronic myeloid leukemia may lead to discontinuation of blood cancer drugs
In a recent study published in Leukemia, Finnish researchers investigated why some patients with chronic myeloid leukemia (CML) can discontinue their daily medication safely.
Frailty status in older adults associated with more adverse events after surgery
A new study from researchers at Wake Forest University School of Medicine shows that frailty is associated with higher rates of death and major morbidity after surgery.
Economist advises gov’t on IMF conditions implementation
By NATION REPORTER
ECONOMIST Noel Kabwita has called on government to put in place practical strategies in the implementation of the International Monetary Fund (IMF) measures with the pending 2nd review of the programme expected to be undertaken.
This content is locked
This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.
Understanding that chronic back pain originates from within the brain could lead to quicker recovery, study finds
Most people with chronic back pain naturally think their pain is caused by injuries or other problems in the body such as arthritis or bulging disks. But our research team has found that thinking about the root cause of pain as a process that’s occurring in the brain can help promote recovery. That is a key finding of a study my colleagues and I recently published in JAMA Network Open, a monthly, open-access medical journal.